Your browser doesn't support javascript.
loading
Antipsychotic drugs in epilepsy.
Górska, Natalia; Slupski, Jakub; Cubala, Wieslaw J.
Afiliación
  • Górska N; Department of Psychiatry, Medical University of Gdansk, Gdansk, Poland. nataliagorska@gumed.edu.pl.
  • Slupski J; Department of Psychiatry, Medical University of Gdansk, Gdansk, Poland.
  • Cubala WJ; Department of Psychiatry, Medical University of Gdansk, Gdansk, Poland.
Neurol Neurochir Pol ; 53(6): 408-412, 2019.
Article en En | MEDLINE | ID: mdl-31681966
ABSTRACT
The prevalence of various psychiatric disorders in people with epilepsy is high, with psychoses affecting 2-9% of patients. Antipsychotic drugs have been identified as increasing the risk of epileptic seizures. For first-generation antipsychotics such a risk appears to be relatively low, with the exception of chlorpromazine. Among second-generation antipsychotics, clozapine use carries the highest risk of seizure induction, while risperidone, quetiapine, amisulpride, and aripiprazole seem to pose a significantly lower risk. The incidence of an increased number of seizures is linked to the elevated blood plasma level effect of antipsychotics. To diminish the risk of seizures, it is important to start with a small dose of antipsychotic drug, to titrate slowly, to monitor serum levels of prescribed drugs, and to keep the drug at the minimal effective dose.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antipsicóticos / Epilepsia Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Neurol Neurochir Pol Año: 2019 Tipo del documento: Article País de afiliación: Polonia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antipsicóticos / Epilepsia Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Neurol Neurochir Pol Año: 2019 Tipo del documento: Article País de afiliación: Polonia